Atherosclerosis Flashcards

1
Q

definition: Arteriosclerosis

A

“Hardening of the arteries” – a group of disorders that have in common thickening and loss of elasticity of arterial walls. Three distinctive
morphological variants are recognised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atherosclerosis

A

progressive disease affecting the intima of elastic and
muscular arteries characterised by focal atheromas (fibrofatty plaques) consisting
of a lipid core covered by a fibrous cap. Atherosclerosis overwhelmingly accounts
for more death and serious morbidity in the Western world than any other
disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Monckeberg’s medial sclerosis

A

characterised by calcification of the media of

muscular arteries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Arteriolosclerosis

A

Characterised by the proliferative or hyaline thickening of the walls of small arteries and arterioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Major predisposing factors for atherosclerosis

A

Diet and hyperlipidaemias (hypercholesterolaemia, hypertriglyceridaemia)
Hypertension – both systolic and diastolic hypertension
Cigarette smoking – esp. responsible for increasing heart disease in women
Diabetes mellitus – 2x risk of myocardial infarct, 8x-150x risk of gangrene of the extremities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Minor predisposing factors for atherosclerosis

A
Obesity
Physical inactivity
Male gender
Increasing age
Family history
Stress (“type A” personality – competitive, stressful lifestyle) - controversial
Oral contraceptives - controversial
High carbohydrate intake - controversial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

AHA stages of atherosclerosis

A

Type I – Lipid is present in macrophages in the intima
Type II – Lipid is present in both macrophages and smooth muscle cells
Type III – Fibrous plaque
Type IV – Complex plaque (fibrous cap overlying a lipid core)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathogenesis of atherosclerosis

A

The lesions of atherosclerosis are initiated as a response to some form of injury to arterial endothelium.
There are roles for endothelial injury, macrophages
and other inflammatory and immunological mechanisms, smooth muscle cell proliferation, hyperlipidaemia and thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endothelial injury: role

A

Endothelial damage is a major risk factor in atherogenesis (well shown in experimental animals) but early lesions in humans develop at sites of intact
endothelium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endothelial damage is a major risk factor in atherogenesis (well
shown in experimental animals) but early lesions in humans develop at sites of intact
endothelium.

A

Monocytes migrate into the intima and then accumulate low-density lipoprotein (LDL) to produce foam cells.

Monocytes/macrophages express the LDL receptor and a specific receptor
(scavenger receptor) for oxidised LDL (oxidised by EC, platelet or white blood cell enzymes).

T cells (CD4+ and CD8+) are found in plaques – role uncertain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Smooth muscle proliferation

A

With lipid accumulation, smooth muscle cell
proliferation and extracellular matrix deposition in the intima are the major processes
for the progressive growth of plaques.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hyperlipidemia

A

Hyperlipoproteinaemia is the abnormality common to most syndromes of premature atherosclerosis.

Can be primary (due to a genetic defect) or
secondary to some other disorder (e.g. nephrotic syndrome, alcoholism, hypothyroidism, and diabetes mellitus). Increases in the plasma level of LDL may
increase the level of lipid penetration in the arterial wall.

Hyperlipoproteinaemia may also directly alter EC function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Infaction definition

A

An infarct is an area of ischaemic necrosis within a tissue or organ,
produced by occlusion of either its arterial supply or its venous drainage.
Infarcts usually result from acute arterial occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

White infarcts occur

A

(1) with arterial occlusion and (2) in solid tissues e.g. heart,
spleen, kidneys.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Red infarcts occur

A

(1) with venous occlusions, (2) in loose tissues e.g. lung, (3) in
tissues with a double circulation e.g. liver and (4) in tissues that are previously
congested.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Transmural infarct (MI)

A

(commonest) – the ischaemic necrosis involves the full or
nearly full thickness of the ventricular wall in the distribution of a single coronary
artery. Usually associated with coronary atherosclerosis, plaque rupture and superimposed
thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Subendocardial Myocardial infarct

A

(= Acute coronary syndrome) – this constitutes an area of ischaemic necrosis limited to the inner one-third, or at most one-half, of the
ventricular wall. There is diffuse stenosing coronary atherosclerosis and global
reduction of coronary flow (e.g. due to shock) but no plaque rupture and no
thrombosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Infarction

Areas of damage undergo a progressive sequence of changes that consists of:

A

typical ischaemic coagulative necrosis, followed by inflammation and repair.

19
Q

20-40 min post MI

A

Ultrastructural changes of irreversible damage

20
Q

2-3h post MI

A

Staining defect with tetrazolium dye (detects dehydrogenase enzymes)

21
Q

4-12 h post MI

A

Classic histological features of necrosis

22
Q

12-24 h post MI

A

Gross alterations visible with the naked eye (pallor or red-blue hue)

23
Q

2-3 days post MI

A

Acute inflammation most prominent

24
Q

5-10 days post MI

A

Macrophages remove necrotic cardiac muscle cells

25
Q

2-4 weeks post MI

A

Granulation tissue most prominent

26
Q

6 weeks post MI

A

scarring well advanced

27
Q

how can you distinguish the age of a well healed old infarct?

A

Once an infarct is well healed, it is impossible to distinguish its age (i.e. an 8-wek-old
and a 10-year-old infarct can look similar.

28
Q

embolisation definition

A

Embolism is the transfer of abnormal material by the bloodstream and its impaction in a vessel.
The impacted material = the embolus.

29
Q

how many presentations of CHEST PAIN a year?

A

600,000
patients
per
year

30
Q

how many have NSTEMI/UA a year?

A

150,000 have UA/NSTEMI (1 in 4)

31
Q

How many have STEMI a year?

A

60 000 (1 in 10)

32
Q

how many dead after stemi in 6 months?

A

12% dead at 6 months!

33
Q

coronary occlusion can result from:

A
  • Atherosclerotic plaque rupture and subsequent thrombus formation
  • Coronary dissection
  • Coronary Spasm
  • Coronary artery embolism
34
Q

other causes of ST elevation

A
  • Acute pericarditis/myocarditis
  • Massive PE (VI‐V2 occasionally)
  • Brugada (V1‐V3 with RBBB morphology)
  • Takotsubo Stress Induced Cardiomyopathy
  • Hyperkalaemia (V1‐V2)
  • Hypothermia
  • Hypercalcaemia
35
Q

secondary prevention after PCI

A
  • Aspirin 75mg
  • Clopidogrel 75mg
  • Bisoprolol
  • Ramipril
  • High dose Statin
  • Cardiac rehab and follow up
  • DVLA: no driving for 1 week post PCI
36
Q

prostaglandin pathway

A

membrane phospholipids (phospholipase A)&raquo_space;> arachidonic acid (COX)»> PG2 (COX)&raquo_space;> PH2&raquo_space; specific enzymes:

1) TXA2 -plt aggregation, vasoconstriction
2) PGI2 aka prostacyclin - vasodilatation, inhibits aggregation, inhibits gastric acid production
3) PGE2 - natriuresis, vasodilatation, inhibits gastric acid production

37
Q

ASPIRIN STUDIES

A

300mg loading dose in AMI
Significant reduction in cardiovascular mortality
(ISIS-2), non-fatal MI and decreased reocclusion
rates following AMI
Reduction in progression from unstable angina
to MI in 40% (RISC)
Secondary prevention: 75mg/day with a
reduction in events

38
Q

Thienopyridines

A

Clopidogrel & Prasugrel
Inhibit ADP-mediated stimulation of the P2Y12 receptor
resulting in inhibition of platelet activation and aggregation
Reduce major cardiac events, thrombosis and restenosis rate
ACS &DES: 12 months clopidogrel; BMS: 1 month
Ex-vivo testing: 34% clopidogrel non-responders

39
Q

effects of nitrates

A
1) Decrease myocardial O2 demand:
Low dose: venodilatation
Larger dose: arterial vasodilatation
2) Improve coronary blood flow:
Dilate coronary arteries
Improve coronary collateral flow
Reverse coronary artery spasm
40
Q

cardiac rupture post MI

A
CARDIAC RUPTURE (1-5 % of cases). Results from the mechanical weakening that occurs in necrotic and inflamed myocardium.
Commonest at 4-7 days post-infarct. Most commonly involves ventricular free wall >>haemopericardium and cardiac tamponade.
Rupture of interventricular septum >> left-to-right shunt. Rupture of papillary muscle -> severe acute mitral incompetence.
41
Q

pericarditis post-mi

A

Usually develops about the 2nd or 3rd day. It is

fibrinous or fibrinohaemorrhagic and is usually localised to the region overlying the necrotic area.

42
Q

mural thrombosis post MI

A

(15-40 % of cases). The combination of a
local myocardial abnormality in contractility (causing stasis) and endocardial damage (causing a thrombogenic surface) leads to mural thrombosis and thromboembolism.

43
Q

ventricualr aneurysm

A

A late complication that most
commonly results from a large anteroseptal, transmural infarct that heals into a large area of thin scar tissue that paradoxically bulges during systole.